AI – Protein Science – Internship 2021-22
Are you looking to experience life in a cutting edge, growing Biotech?
Do you have an interest in protein engineering/TCR biology/immunology?
Do you have an innate scientific curiosity?
Do you possess practical laboratory experience?
Are you a team player?
Do you have great attention to detail and a huge amount of self-motivation?
If the answer is YES! to all of the above, please read on…
Immunocore is a late-stage biotechnology company pioneering the development of a novel class of TCR bispecific immunotherapies designed to treat a broad range of diseases, including cancer, infection and autoimmune disease. We are developing a deep pipeline in multiple therapeutic areas, including five clinical stage programs in oncology and infectious disease, advanced pre-clinical programs in autoimmune disease and multiple earlier pre-clinical programs.
Our most advanced oncology therapeutic candidate, tebentafusp, has demonstrated an overall survival benefit in a randomized Phase 3 clinical trial in metastatic uveal melanoma, a cancer that has historically proven to be insensitive to other immunotherapies. The company also recently completed its Initial Public Offering and was listed on the NASDAQ.
We pride ourselves on our long-standing and established academic collaborations and as a result, we have an opportunity for a 12 month Internship programme in our Autoimmune Protein Science Group. Within the group, this internship will focus on using protein engineering to design and develop novel autoimmune therapies. We are looking for an enthusiastic and highly motivated individual who would relish the chance to learn from Immunocore’s cutting edge science and contribute to this dynamic research area.
CLOSING DATE - 29th April 2021
INTERVIEWS - w/c 17th and 24th May 2021
If this opportunity excites you, please don’t hesitate in applying today!